Pacific Bio down 8% after hours on U.S. opposition on Illumina tie-up

Pacific Biosciences of California (NASDAQ:PACB) slips 8% after hours in response to reports that U.S. regulators will seek to block its $1.2B merger with Illumina (NASDAQ:ILMN).

https://seekingalpha.com/news/3526937-pacific-bio-down-8-after-hours-on-u-s-opposition-on-illumina-tie-up